Global Prokinetic Drug Sales Market Report 2021

A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.

Market Analysis and Insights: Global Prokinetic Drug Market
The global Prokinetic Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Prokinetic Drug Scope and Market Size
The global Prokinetic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prokinetic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Metoclopramide
Domperidone
Cisapride
Others

Segment by Application
Gastroparesis
Constipation
Reflux Esophagitis
Functional Dyspepsia

The Prokinetic Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Prokinetic Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer
Teva
Cadila Pharmaceuticals
Hanmi Pharm